CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii
Open Access
- 27 October 2021
- journal article
- research article
- Published by American Society for Microbiology in mSphere
- Vol. 6 (5) , e0047421
Abstract
Toxoplasma gondiiis a ubiquitous intracellular parasite of humans and animals that causes life-threatening disease in immunocompromised patients, fetal abnormalities when contracted during gestation, and recurrent eye lesions in some patients. Despite its health implications, about half of theToxoplasmagenome still lacks functional annotation.Keywords
Funding Information
- Damon Runyon Cancer Research Foundation (DRG-2365-19)
- HHS | National Institutes of Health (1R01AI144369)
- Boehringer Ingelheim Fonds
This publication has 38 references indexed in Scilit:
- CRISPR interference (CRISPRi) for sequence-specific control of gene expressionNature Protocols, 2013
- Orthogonal Cas9 proteins for RNA-guided gene regulation and editingNature Methods, 2013
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in EukaryotesCell, 2013
- Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas systemNucleic Acids Research, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Rapid control of protein level in the apicomplexan Toxoplasma gondiiNature Methods, 2007
- CRISPR Provides Acquired Resistance Against Viruses in ProkaryotesScience, 2007
- Role of Toxoplasma gondii Myosin A in Powering Parasite Gliding and Host Cell InvasionScience, 2002
- Transient Transfection and Expression in the Obligate Intracellular Parasite Toxoplasma gondiiScience, 1993